Type 1 diabetes: treatment [sounds like]
299 results
1 - 100Type 1 diabetes: treatment
- Essentials
- Investigating high-blood-glucose homeostasis and variation of blood glucose concentrations
- Targets for glycaemic control
- Multiple injection regime and travel across time zones
- References
- Assessing appropriate insulin dose
- Principles of insulin administration
- Utilization of self-monitoring of blood glucose
- Injection of insulin
- Dietary principles
- Physical exercise and insulin treatment
- Hypoglycaemia
- Hyperglycaemia
Hormone replacement therapy for women with type 1 diabetes mellitus: Cochrane systematic review
Metformin in the treatment of type II diabetes
Newly diagnosed type 1 diabetes in a child
Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents New
Hydrolyzed infant formula does not reduce the risk of type 1 diabetes
Oral antidiabetic drugs and GLP-1 analogues
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus: Cochrane systematic review
Enhanced glucose control for preventing and treating diabetic neuropathy: Cochrane systematic review
Glimepiride in the treatment of type 2 diabetes
Gestational diabetes mellitus (GDM)
Group based training for self-management strategies in people with type 2 diabetes mellitus
Treatment and follow-up in type 2 diabetes
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus New
Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus Edited (no change to conclusions)
Type 1 diabetes in fair to good control not associated with reduced school performance in children
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review
Intermediate acting versus long acting insulin for type 1 diabetes mellitus New
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
Dietary advice and exercise for type 2 diabetes mellitus
Different insulin types and regimens for pregnant women with pre-existing diabetes: Cochrane systematic review
Exercise for pregnant women with pre-existing diabetes for improving maternal and fetal outcomes: Cochrane systematic review
Risk of severe hypoglycemia similar between different insulin formulations
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia: Cochrane systematic review
Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus: Cochrane systematic review
Continuous subcutaneous insulin infusion for type 1 diabetes
Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
Risk test for type 2 diabetes
Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance: Cochrane systematic review
Individualizing target goals and treatment in patients with type 2 diabetes
Rosiglitazone for type 2 diabetes mellitus
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus Edited (no change to conclusions)
Linagliptin and glimepiride equally effective for adults with type 2 diabetes
Hyperbaric O2 therapy may improve diabetic foot ulcers
Dietary advice for the prevention of type 2 diabetes mellitus in adults: Cochrane systematic review
A child or adolescent with type 1 diabetes in primary health care
No benefit to screening with CT angiography for asymptomatic CAD in adults with diabetes
Exercise and diet for preventing type 2 diabetes mellitus
Linagliptin and glimepiride equally effective for adults with type 2 diabetes: POEM amended to include Canadian pricing
Metformin monotherapy for adults with type 2 diabetes mellitus New
NICE guidelines for diabetes mellitus, type 2
Cinnamon for diabetes mellitus: Cochrane systematic review
Severe hypoglycemic episodes raise risk of dementia in adults with T2DM
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
Diabetes: definition, differential diagnosis and classification
Mediterranean diet delays treatment of type 2 diabetes
Blood pressure control for diabetic retinopathy: Cochrane systematic review
Intensive control of blood sugar (HbA1c < 7.0%) in DM2 may be harmful (ACCORD)
Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
Metformin minimally beneficial, if at all, when added to insulin in overweight adolescents with T1DM
Uncertain if tight control reduces long-term mortality in patients with T1DM
Metformin should be initial therapy for adults with type 2 DM
Fenofibrate decreases amputation in patients with type 2 DM (FIELD)
Diabetic kidney disease (diabetic nephropathy)
J-shaped survival curve for glycemic control in patients with type 2 DM
Similar long-term morbidity and mortality with human insulin and analogue insulins
Insulin therapy in type 2 diabetes
Liraglutide for weight loss among patients with type 2 diabetes
Home glucose monitoring offers no benefit to patients not using insulin
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
Altered dietary salt intake for preventing and treating diabetic kidney disease: Cochrane systematic review
Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease